During the past decade, Tokyo Women's Medical University Hospital; Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Women's Medical University Hospital; Neurology" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Women's Medical University Hospital; Neurology" are "Generalized Myasthenia Gravis" (1 trials), "NMO Spectrum Disorder (NMOSD)" (1 trials) and "Neuromyelitis Optica (NMO)" (1 trials). Many other conditions were trialed in "Tokyo Women's Medical University Hospital; Neurology" in a lesser frequency.

Most popular intervention types in "Tokyo Women's Medical University Hospital; Neurology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Satralizumab" (2 trials) and "Baseline Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Women's Medical University Hospital; Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Women's Medical University Hospital; Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tokyo Women's Medical University Hospital; Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Women's Medical University Hospital; Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".